55 related articles for article (PubMed ID: 9865726)
21. Kinase inhibitor profile for human nek1, nek6, and nek7 and analysis of the structural basis for inhibitor specificity.
Moraes EC; Meirelles GV; Honorato RV; de Souza Tde A; de Souza EE; Murakami MT; de Oliveira PS; Kobarg J
Molecules; 2015 Jan; 20(1):1176-91. PubMed ID: 25591119
[TBL] [Abstract][Full Text] [Related]
22. Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development.
Senese S; Lo YC; Huang D; Zangle TA; Gholkar AA; Robert L; Homet B; Ribas A; Summers MK; Teitell MA; Damoiseaux R; Torres JZ
Cell Death Dis; 2014 Oct; 5(10):e1462. PubMed ID: 25321469
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of checkpoint kinase targeting therapy in acute myeloid leukemia with complex karyotype.
Didier C; Demur C; Grimal F; Jullien D; Manenti S; Ducommun B
Cancer Biol Ther; 2012 Mar; 13(5):307-13. PubMed ID: 22258035
[TBL] [Abstract][Full Text] [Related]
24. Modern natural products drug discovery and its relevance to biodiversity conservation.
Kingston DG
J Nat Prod; 2011 Mar; 74(3):496-511. PubMed ID: 21138324
[TBL] [Abstract][Full Text] [Related]
25. Marine pyrrolocarbazoles and analogues: synthesis and kinase inhibition.
Deslandes S; Chassaing S; Delfourne E
Mar Drugs; 2009 Dec; 7(4):754-86. PubMed ID: 20098609
[TBL] [Abstract][Full Text] [Related]
26. A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53.
Sur S; Pagliarini R; Bunz F; Rago C; Diaz LA; Kinzler KW; Vogelstein B; Papadopoulos N
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3964-9. PubMed ID: 19225112
[TBL] [Abstract][Full Text] [Related]
27. Lamellarins and related pyrrole-derived alkaloids from marine organisms.
Fan H; Peng J; Hamann MT; Hu JF
Chem Rev; 2008 Jan; 108(1):264-87. PubMed ID: 18095718
[No Abstract] [Full Text] [Related]
28. Mechanism targeted discovery of antitumor marine natural products.
Nagle DG; Zhou YD; Mora FD; Mohammed KA; Kim YP
Curr Med Chem; 2004 Jul; 11(13):1725-56. PubMed ID: 15279579
[TBL] [Abstract][Full Text] [Related]
29. Chemical genetics: ligand-based discovery of gene function.
Stockwell BR
Nat Rev Genet; 2000 Nov; 1(2):116-25. PubMed ID: 11253651
[TBL] [Abstract][Full Text] [Related]
30. p53 regulation of G(2) checkpoint is retinoblastoma protein dependent.
Flatt PM; Tang LJ; Scatena CD; Szak ST; Pietenpol JA
Mol Cell Biol; 2000 Jun; 20(12):4210-23. PubMed ID: 10825186
[TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationships for G2 checkpoint inhibition by caffeine analogs.
Jiang X; Lim LY; Daly JW; Li AH; Jacobson KA; Roberge M
Int J Oncol; 2000 May; 16(5):971-8. PubMed ID: 10762633
[TBL] [Abstract][Full Text] [Related]
32. Cell cycle checkpoints as therapeutic targets.
Stewart ZA; Pietenpol JA
J Mammary Gland Biol Neoplasia; 1999 Oct; 4(4):389-400. PubMed ID: 10705922
[TBL] [Abstract][Full Text] [Related]
33. [Potentiation of radiosensitivity by staurosporine associated with abrogation of G2 phase arrest].
Sun XC; Wang JJ; Zhen YS; Shao RG
Yao Xue Xue Bao; 2002 Jun; 37(6):419-23. PubMed ID: 12579796
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide.
Jiang X; Zhao B; Britton R; Lim LY; Leong D; Sanghera JS; Zhou BB; Piers E; Andersen RJ; Roberge M
Mol Cancer Ther; 2004 Oct; 3(10):1221-7. PubMed ID: 15486189
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of the G2 DNA damage checkpoint and their potential for cancer therapy.
Anderson HJ; Andersen RJ; Roberge M
Prog Cell Cycle Res; 2003; 5():423-30. PubMed ID: 14593736
[TBL] [Abstract][Full Text] [Related]
36. New okadaic acid analogues from the marine sponge Merriamum oxeato and their effect on mitosis.
Britton R; Roberge M; Brown C; van Soest R; Andersen RJ
J Nat Prod; 2003 Jun; 66(6):838-43. PubMed ID: 12828471
[TBL] [Abstract][Full Text] [Related]
37. High-throughput assay for G2 checkpoint inhibitors and identification of the structurally novel compound isogranulatimide.
Roberge M; Berlinck RG; Xu L; Anderson HJ; Lim LY; Curman D; Stringer CM; Friend SH; Davies P; Vincent I; Haggarty SJ; Kelly MT; Britton R; Piers E; Andersen RJ
Cancer Res; 1998 Dec; 58(24):5701-6. PubMed ID: 9865726
[TBL] [Abstract][Full Text] [Related]
38. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
